What to Consider if Your Drug is a Targeted Therapy for a New Biomarker
A Follow Up to “Biomarker Testing in Non-Small Cell Lung Cancer“ By Melissa Leonhauser, General...
A Follow Up to “Biomarker Testing in Non-Small Cell Lung Cancer“ By Melissa Leonhauser, General...
Clinical Diagnostic Data for Omnichannel HCP Promotion Marketing: Part Two We’re excited to share...
By Bill Bowman, Clinical Solutions Architect
A 5 Part Series By Matt Apprendi, VP of Digital Products We’re excited to write about one of the...
Wouldn’t it be convenient if a doctor could simply upload a patient’s medical chart into an...
By Theresa Greco, Chief Commercial Officer
Diabetes is one of many conditions where lab testing plays a critical role.
Rather than prescribing every cancer patient the same treatment regimen, oncologists and other...